Prognostic indices in heart transplant candidates after the first hospitalization triggered by the need for intravenous pharmacologic circulatory support

Journal of Heart and Lung Transplantation

Volumn 18, Issue 7, 1999, Pages 654-663

  Gronda, Edoardo G ^a   Barbieri, Pietro ^c   Frigerio, Maria ^a   Mangiavacchi, Maurizio ^a   Oliva, Fabrizio ^a   Quaini, Eugenio ^b   Andreuzzi, Bruno ^a   Garascia, Andrea ^a   De Vita, Claudio ^a   Pellegrini, Alessandro ^b  

^a 1st Div Gasperis Ctr Niguarda H   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMIODARONE; AMRINONE; ANTIARRHYTHMIC AGENT; BILIRUBIN; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; ENOXIMONE; ETACRYNIC ACID; FUROSEMIDE; HYDRAZINE; HYDROCHLOROTHIAZIDE; METOLAZONE; NITRATE; NITROPRUSSIDE SODIUM; SODIUM; UREA; VASODILATOR AGENT;

ADULT; ARTICLE; ASSISTED CIRCULATION; BILIRUBIN BLOOD LEVEL; HEART FAILURE; HEART RIGHT ATRIUM PRESSURE; HEART TRANSPLANTATION; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MORTALITY; ORGAN DONOR; PRIORITY JOURNAL; PROGNOSIS; SODIUM BLOOD LEVEL; SURVIVAL RATE; UREA NITROGEN BLOOD LEVEL;

ADOLESCENT; ADULT; CARDIOVASCULAR AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HEMODYNAMIC PROCESSES; HOSPITALIZATION; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 0032809094     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(99)00020-0     Document Type: Article

References (19)

1. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med. 316:1987;1429-1435.
2. Effects of Enalapril on survival in patients with reduced left ventricular ejection fractions and severe congestive heart failure. N Engl J Med. 325:1991;293-302.
3. Packer M., Bristow M.R., Cohn J.N., et al. Effect of carvedilol on the survival of patients with congestive heart failure. Circulation. 92:(suppl. I):1995;I142.
4. Stevenson W.G., Stevenson L.W., Middlekauff H.R., et al. Improving survival for patients with advanced heart failure: a study of 737 consecutive patients. J Am Coll Cardiol. 26:1995;1417-1423.
5. Stevenson L.W., Tillish J.H., Hamilton M.A., et al. Importance of hemodynamic response in predicting survival with ejection fraction ≤20% secondary to ischemic or non ischemic cardiomyopathy. Am J Cardiol. 66:1990;1348-1354.
6. Breslow NE, Day NE. Statistical methods in carcer research. Vol 1: The analysis of case-control studies. Lyon, France: IARC Scientific Publications; 1981, N32.
7. Kaplan E.L., Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
8. Cox D.R. Regression models and life-tables. J R Stat Soc. B34:1972;87-220.
9. Mancini D.M., Eisen H., Kussmaul W., Mull R., Edmund L.H., Wilson J.R. Value of peak exercise oxygen consumption for optimal firming of cardiac transplantation in ambulatory patients with heart failure. Circulation. 83:1991;778-786.
10. Stevenson L.W. Tailored therapy before transplantation for treatment of advanced congestive heart failure: effective use of vasodilators and diuretics. J Heart Lung Transplant. 10:1991;468-476.
11. Spencer H.K., Walter B.A., David H.A.J., Clark M.C., Cody R.J. Liver function abnormalities in chronic heart failure: influence of systemic hemodynamics. Arch Intern Med. 147:1987;1227-1230.
12. Frigerio M., Gronda E., Danzi G.B., Mangiavacchi M., Oliva F., Quaini E., et al. Short-term survival after heart transplantation: relationships between preoperative hemodynamics, end-organ dysfunction and postoperative events. G Italian Cardiol. 25:1995;1-9.
13. Ferrar D.J. Preoperative predictors of survival with thoratec ventricular assist devices as bridge to heart transplantation. J Heart Lung Transplant. 13:1994;93-101.
14. Morley D., Brozena S.C. Assessing the risk in patients awaiting cardiac transplantation. Am J Cardiol. 73:1994;379-383.
15. Gradman A.H., Deedwania P.C. Predictors of mortality in patients with heart failure. Cardiol Clin. 12:1994;25-35.
16. Levine B.T., Levine B.L., Goldberg D., Narins B., Goldstein S., Lesh M. Reversal of end stage heart failure is predicted by long term therapeutic response rather than initial hemodynamic and neurohormonal profile. J Heart Lung Transplant. 15:1996;297-303.
17. Stevenson L.W., Warner S.L., Steimle A.L., et al. The impending crisis awaiting cardiac transplantation: modeling a solution based upon selection. Circulation. 89:1994;450-457.
18. Oz M.C., Goldstein D.J., Pepino P., Weinberg A.D., Thompson S.M., Catanese K.A., Vargo R.L., McCarthy P.M., Rose E.A., Levin H.R. Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices. Circulation. 92:(Suppl. II):1995;II169-II173.
19. Hill J.D., Lemperle B., Levinson M., Poirer V.L., Griffith B.P. How much we need to know before approving a ventricular assist device? Ann Thor Surg. 55:1993;314-328.